Ítem
Solo Metadatos
Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine
dc.creator | Ocampo, Marisol | |
dc.creator | Patarroyo, Manuel A. | spa |
dc.creator | Vanegas, Magnolia | spa |
dc.creator | Alba, Martha P. | spa |
dc.creator | Patarroyo, Manuel E. | spa |
dc.date.accessioned | 2020-05-26T00:05:21Z | |
dc.date.available | 2020-05-26T00:05:21Z | |
dc.date.created | 2014 | spa |
dc.description.abstract | Tuberculosis (TB) is an air-born, transmissible disease, having an estimated 9.4 million new TB cases worldwide in 2009. Eventual control of this disease by developing a safe and efficient new vaccine able to detain its spread will have an enormous impact on public health policy. Selecting potential antigens to be included in a multi-epitope, minimal subunit-based, chemically-synthesized vaccine containing the minimum sequences needed for blocking mycobacterial interaction with host cells is a complex task due to the multiple mechanisms involved in M. tuberculosis infection and the mycobacterium's immune evasion mechanisms. Our methodology, described here takes into account a highly robust, specific, sensitive and functional approach to the search for potential epitopes to be included in an anti-TB vaccine; it has been based on identifying short mycobacterial protein fragments using synthetic peptides having high affinity interaction with alveolar epithelial cells (A549) and monocyte-derived macrophages (U937) which are able to block the microorganism's entry to target cells in in vitro assays. This manuscript presents a review of the results obtained with some of the MTB H37Rv proteins studied to date, aimed at using these high activity binding peptides (HABPs) as platforms to be included in a minimal subunit-based, multiepitope, chemically-synthesized, antituberculosis vaccine. © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.3109/1040841X.2013.763221 | |
dc.identifier.issn | 15497828 | |
dc.identifier.issn | 1040841X | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23782 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 145 | |
dc.relation.citationIssue | No. 2 | |
dc.relation.citationStartPage | 117 | |
dc.relation.citationTitle | Critical Reviews in Microbiology | |
dc.relation.citationVolume | Vol. 40 | |
dc.relation.ispartof | Critical Reviews in Microbiology, ISSN:15497828, 1040841X, Vol.40, No.2 (2014); pp. 117-145 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891085960&doi=10.3109%2f1040841X.2013.763221&partnerID=40&md5=ed6960a662a4b4df4c6560ddc2487e93 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Bacterial antigen | spa |
dc.subject.keyword | Bacterial protein | spa |
dc.subject.keyword | Bcg vaccine | spa |
dc.subject.keyword | Rv 0180 c protein | spa |
dc.subject.keyword | Rv 0227 c protein | spa |
dc.subject.keyword | Rv 0679 c protein | spa |
dc.subject.keyword | Rv 1490 protein | spa |
dc.subject.keyword | Rv 1510 c protein | spa |
dc.subject.keyword | Rv 1980 c protein | spa |
dc.subject.keyword | Rv 2004 c protein | spa |
dc.subject.keyword | Rv 2301 protein | spa |
dc.subject.keyword | Rv 2536 protein | spa |
dc.subject.keyword | Rv 2560 protein | spa |
dc.subject.keyword | Rv 2707 protein | spa |
dc.subject.keyword | Rv 2969c protein | spa |
dc.subject.keyword | Rv 3166 c protein | spa |
dc.subject.keyword | Rv 3481 c protein | spa |
dc.subject.keyword | Rv 3629 c protein | spa |
dc.subject.keyword | Rv 3630 protein | spa |
dc.subject.keyword | Rv 3804 c protein | spa |
dc.subject.keyword | Rv 3910 protein | spa |
dc.subject.keyword | Synthetic peptide | spa |
dc.subject.keyword | Unclassified drug | spa |
dc.subject.keyword | Bioinformatics | spa |
dc.subject.keyword | Immune response | spa |
dc.subject.keyword | Molecular biology | spa |
dc.subject.keyword | Mycobacterium tuberculosis | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Protein analysis | spa |
dc.subject.keyword | Protein binding | spa |
dc.subject.keyword | Protein function | spa |
dc.subject.keyword | Proteomics | spa |
dc.subject.keyword | Review | spa |
dc.subject.keyword | Three dimensional imaging | spa |
dc.subject.keyword | Antigens | eng |
dc.subject.keyword | Bacterial adhesion | spa |
dc.subject.keyword | Bacterial proteins | spa |
dc.subject.keyword | Cell line | spa |
dc.subject.keyword | Epithelial cells | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Macrophages | spa |
dc.subject.keyword | Mycobacterium tuberculosis | spa |
dc.subject.keyword | Tuberculosis vaccines | spa |
dc.subject.keyword | Mycobacterium tuberculosis surface protein | spa |
dc.subject.keyword | Receptor-ligand interaction | spa |
dc.subject.keyword | Subunit-vaccine | spa |
dc.subject.keyword | Synthetic-peptides | spa |
dc.title | Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |